On February 27th 2019, ABC10-News broadcasted a portrait of the project Summit4StemCell. Jennifer Raub, who is the president of the charitable SummitForStemCell Foundation, talks about her Parkinson's disease and the clinical trial of the unique cell replacement therapy, which is close at hand.
Read more ...In October 2018 in Japan, for the first time in the world, a Parkinson’s patient was treated with reprogrammed stem cells. The man in his 50s was implanted at the University of Kyoto with dopamine progenitor cells, previously extracted from the cell material of an anonymous donor.
Read more ...In particular, for Parkinson's patients who are otherwise physically still healthy, cell replacement therapies could mean the return to a largely normal life.
It has to be noted, however, that the cause(s) for dopamine cell death in the brain, which led to the onset of Parkinson's disease, are different for each individual affected.
Therefore, it is likely that these original causes are not cured by cell replacement therapies. Thus, cell replacement therapies, when used alone, have only a limited duration of action since the transplanted cells can also slowly die off after a certain time. However, according to current knowledge the duration of the activity can be very long (many years up to several decades).
Thus, cell replacement therapy is "only" one of several pillars in the cure of Parkinson's disease. For those affected, however, it is very important, because this therapy can significantly improve the quality of life.
Other pillars include: